Estimating benefit from dose dense adjuvant chemotherapy for early breast cancer in the PANTHER randomized phase 3 trial

被引：0
作者：
Matikas, Alexios
Gnant, Michael
Johansson, Hemming
Untch, Michael
Tsiknakis, Nikolaos
Greil, Richard
Loibl, Sibylle
Foukakis, Theodoros
Bergh, Jonas C. S.
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
[4] Helios Klinikum Berlin Buch, Berlin, Germany
[5] Paracelsus Med Univ, Canc Cluster Salzburg, Ctr Clin Canc & Immunol Trials, Med Dept 3,Salzburg Canc Res Inst, Salzburg, Austria
[6] GBG Forsch GmbH, Neu Isenburg, Germany
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Karolinska Univ Hosp, Karolinska Comprehens Canc Ctr, Breast Canc Ctr, Canc Theme, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
521
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer
    Criscitiello, Carmen
    Viale, Giulia
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 472 - 479
  • [32] Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer
    Mayer, Erica L.
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1198 - 1200
  • [33] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    A. Sverrisdottir
    M. Nystedt
    H. Johansson
    T. Fornander
    Breast Cancer Research and Treatment, 2009, 117
  • [34] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    Sverrisdottir, A.
    Nystedt, M.
    Johansson, H.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 561 - 567
  • [35] Prognostic Tools in Early Breast Cancer: Predicting benefit of adjuvant chemotherapy
    Parkes, E. E.
    Davidson, C.
    James, C. R.
    Hanna, G. G.
    CANCER RESEARCH, 2012, 72
  • [36] Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials
    Petrelli, Fausto
    Cabiddu, Mary
    Coinu, Andrea
    Borgonovo, Karen
    Ghilardi, Mara
    Lonati, Veronica
    Barni, Sandro
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (02) : 251 - 259
  • [37] Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
    Arriagada, R
    Lê, MG
    Spielmann, M
    Mauriac, L
    Bonneterre, J
    Namer, M
    Delozier, T
    Hill, C
    Tursz, T
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 389 - 396
  • [38] PROGNOSTIC TOOLS IN EARLY BREAST CANCER: PREDICTING BENEFIT OF ADJUVANT CHEMOTHERAPY
    Parkes, E. E.
    Davidson, C.
    Hussain, A.
    James, C. R.
    Hanna, G. G.
    ANNALS OF ONCOLOGY, 2012, 23 : 107 - 107
  • [39] Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials
    Fausto Petrelli
    Mary Cabiddu
    Andrea Coinu
    Karen Borgonovo
    Mara Ghilardi
    Veronica Lonati
    Sandro Barni
    Breast Cancer Research and Treatment, 2015, 151 : 251 - 259
  • [40] Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
    Blondeaux, Eva
    Lambertini, Matteo
    Michelotti, Andrea
    Conte, Benedetta
    Benasso, Marco
    Dellepiane, Chiara
    Bighin, Claudia
    Pastorino, Simona
    Levaggi, Alessia
    D' Alonzo, Alessia
    Poggio, Francesca
    Buzzatti, Giulia
    Molinelli, Chiara
    Fregatti, Piero
    Bertoglio, Sergio
    Boccardo, Francesco
    Del Mastro, Lucia
    BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1611 - 1617
12345